Research progress in the mechanism and treatment of osteosarcoma
Top Cited Papers
Open Access
- 31 August 2023
- journal article
- review article
- Published by Wolters Kluwer Health in Chinese Medical Journal
- Vol. 136 (20) , 2412-2420
Abstract
Osteosarcoma (OS) is the most common primary malignant bone tumor that more commonly occurs in children and adolescents. The most commonly used treatment for OS is surgery combined with chemotherapy, but the treatment outcomes are typically unsatisfactory. High rates of metastasis and post-treatment recurrence rates are major challenges in the treatment of OS. This underlines the need for studying the in-depth characterization of the pathogenetic mechanisms of OS and development of more effective therapeutic modalities. Previous studies have demonstrated the important role of the bone microenvironment and the regulation of signaling pathways in the occurrence and development of OS. In this review, we discussed the available evidence pertaining to the mechanisms of OS development and identified therapeutic targets for OS. We also summarized the available treatment modalities for OS and identified future priorities for therapeutics research.Keywords
This publication has 86 references indexed in Scilit:
- Phase I Clinical Trial of Ipilimumab in Pediatric Patients with Advanced Solid TumorsClinical Cancer Research, 2016
- Dendritic cells combined with anti-GITR antibody produce antitumor effects in osteosarcomaOncology Reports, 2015
- Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled TrialJournal of Clinical Oncology, 2015
- Ribosomal protein S3 regulates GLI2-mediated osteosarcoma invasionCancer Letters, 2015
- Knockdown of galectin-1 suppresses the growth and invasion of osteosarcoma cells through inhibition of the MAPK/ERK pathwayOncology Reports, 2014
- The MAPK pathway across different malignancies: A new perspectiveCancer, 2014
- Interferon-α suppresses invasion and enhances cisplatin-mediated apoptosis and autophagy in human osteosarcoma cellsOncology Letters, 2013
- Enhancement of antitumor immunity by combining anti-cytotoxic T lymphocyte antigen-4 antibodies and cryotreated tumor lysate-pulsed dendritic cells in murine osteosarcomaOncology Reports, 2013
- Wnt10b activates the wnt, notch, and NFκB pathways in u2os osteosarcoma cellsJournal of Cellular Biochemistry, 2011
- Smoothened as a new therapeutic target for human osteosarcomaMolecular Cancer, 2010